Successful use of the Cardiva Boomerang™ vascular closure device to close a brachial artery puncture site after emergency PTCA

2010 ◽  
Vol 25 (6) ◽  
pp. 565-568 ◽  
Author(s):  
Plinio Cirillo ◽  
Gianluca Petrillo ◽  
Greta Luana D’Ascoli ◽  
Federico Piscione ◽  
Massimo Chiariello
Keyword(s):  
Brachial Artery ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Puncture Site

Evaluation of the MANTA Vascular Closure Device in Transfemoral TAVI

2021 ◽  
Author(s):  
Lukasz Kmiec ◽  
Matthaeus Zerdzitzki ◽  
Christof Schmid ◽  
Kurt Debl ◽  
Samuel Sossalla ◽  
...  
Keyword(s):  
Academic Research ◽  
Case Series ◽  
Vascular Complications ◽  
Female Gender ◽  
Closure Device ◽  
Complication Rates ◽  
Imaging Data ◽  
Patient Death ◽  
Vascular Closure Device ◽  
Puncture Site

Abstract Background The MANTA vascular closure device (VCD) is a novel collagen plug-based VCD for large bore arteriotomies. The current literature regarding complication rates of this device is quite variable and mostly limited to relatively small case series. Methods This study is retrospective analysis of the MANTA VCD-related main access site complications according to Valve Academic Research Consortium-2 (VARC-2) criteria during the hospital stay. Particular attention was paid to the detailed analysis of multislice computed tomography with regard to the anatomy of the access vessel and the puncture site itself. Results A total of 524 patients underwent transfemoral transcatheter aortic valve implantation (TF TAVI) including the use of the MANTA device (18F) for percutaneous vascular closure. A group of 22 patients was excluded from the study due to incomplete imaging data. During the study period, we observed 28 major (5.6%) and five minor (1.0%) MANTA device-related vascular complications. There was no patient death related to these adverse events. Female gender, vessel angulation at the puncture site, and at least moderate calcification of the dorsal vessel segment were identified as independent predictors for major complications. Conclusions The MANTA device is a feasible option for vascular closure of large bore arteriotomies in patients undergoing TF TAVI or other percutaneous transfemoral interventions. Furthermore, we have identified novel predictors for device failure/complications that should be taken into account for selection of the appropriate closure device. To our knowledge, this report is one of the largest case series analyzing the use of the MANTA VCD.

scholarly journals Success and reliability of extrafemoral Exoseal vascular closure device: “Off-label” usage

2020 ◽  
Vol 11 (3) ◽  
pp. 182-186
Author(s):  
Ismail Caymaz ◽  
Fuad Nurili ◽  
Ozlem Kolcak ◽  
Omer Aras ◽  
Burcak Gumus
Keyword(s):  
Brachial Artery ◽  
Large Scale ◽  
Endovascular Procedures ◽  
Covered Stent ◽  
Closure Device ◽  
Minor Complication ◽  
Technical Success ◽  
Vascular Closure Device ◽  
Artery Pseudoaneurysm ◽  
Procedural Success

Aim The aim of this study is to present the reliability and efficacy of Exoseal vascular closure device (EVCD) for closure of extrafemoral punctures. Materials and methods All patients who were treated with EVCD following arterial endovascular treatment involving an extrafemoral puncture between April 2013 and January 2014 were examined retrospectively. This study included 11 patients (4 women and 7 men between the ages of 48 and 87 years; average age = 65 years). A total of 13 procedures were performed in 11 patients involving the following access routes: brachial artery (n = 5), popliteal artery (n = 4), and polytetrafluoroethylene graft (n = 4). Results Twelve out of 13 EVCD procedures achieved technical success and procedural success. One minor and one major complications occurred. Both complications were revealed to be pseudoaneurysms, both in the brachial artery. Pseudoaneurysm of the minor complication was treated by Fibrin Sealant (Tisseel) injection guided by ultrasonography and the other pseudoaneurysm was treated by covered stent placement. Conclusions The femoral artery is an essential access route of arterial endovascular procedures; however, in some cases, the extrafemoral arterial route is necessary. In this study, EVCD was found to be useful for closing extrafemoral arterial routes. This study had a limited number of cases and more large-scale studies are needed.

Closure of femoral artery puncture site with antegrade placement of Prostar XL vascular closure device

2014 ◽  
Vol 2 (3) ◽  
pp. 42
Author(s):  
Bozkurt Gulek ◽  
Onur Ergun ◽  
Turkmen Ciftci ◽  
Yavuz Kutlu ◽  
Bora Peynircioglu ◽  
...  
Keyword(s):  
Femoral Artery ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Puncture Site

Suitability of Exoseal Vascular Closure Device for Antegrade Femoral Artery Puncture Site Closure

2012 ◽  
Vol 36 (3) ◽  
pp. 659-668 ◽  
Author(s):  
Christopher Schmelter ◽  
Andrea Liebl ◽  
Nektarios Poullos ◽  
Volker Ruppert ◽  
Dierk Vorwerk
Keyword(s):  
Femoral Artery ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Puncture Site

FemoSeal® vascular closure device for antegrade common femoral artery access: Safety and technical notes

2019 ◽  
Vol 21 (1) ◽  
pp. 79-85 ◽  
Author(s):  
Francesco Bruno Tagliaferro ◽  
Gianluigi Orgera ◽  
Luca Mascagni ◽  
Florindo Laurino ◽  
Marcello Andrea Tipaldi ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Platelet Count ◽  
Femoral Artery ◽  
Partial Thromboplastin Time ◽  
Common Femoral Artery ◽  
International Normalized Ratio ◽  
Closure Device ◽  
Technical Success ◽  
Vascular Closure Device ◽  
Puncture Site

Purpose: To retrospectively assess the efficacy and safety of FemoSeal® vascular closure device to achieve hemostasis following antegrade common femoral artery puncture after lower limb revascularization using vascular sheaths from 5 to 8 Fr. Methods: We reviewed the hemostatic outcome achieved with FemoSeal in 103 consecutive patients (mean age: 69 ± 8 years, 71 males) that undergone to 111 antegrade common femoral artery accesses for percutaneous lower limbs revascularization using 5- to 8-Fr vascular sheaths. We used FemoSeal in an unselected population, without exclusion criteria. The primary outcome was the technical success, meant as achieving complete hemostasis without immediate complications. Results: Hemostasis was achieved in all 111 puncture sites (100% technical success). We observed eight (7%) puncture site minor complications (hematomas), none of which affecting the patients’ outcome or requiring further therapies or increasing the hospital stay. There were no statistically significant differences between the variables potentially related to the occurrence of complications (age, international normalized ratio, platelet count, partial thromboplastin time ratio, body mass index, and common femoral arteries calcification grade) in patients with and without complications. Complications group mean body mass index was 26.4 ± 2.8 kg/m2 versus non-complications group 26.6 ± 4.4 kg/m2, p = 0.92. Mean international normalized ratio and partial thromboplastin time ratio were 1.05 ± 0.01 and 1.05 ± 0.14 versus 1.13 ± 0.2 (p = 0.39) and 1.12 ± 0.23 (p = 0.53), respectively. Common femoral arteries calcification grade was the same (mean: 1, p = 1). Platelet count was 202 × 103/mL ± 66.7 versus 226 × 103/mL ± 91.2, p = 0.55. Mean age was 72.3 ± 10 years versus 72.8 ± 8 years, p = 0.86. Conclusion: The low rate (7%) and grading of the adverse events, combined with the high technical success rate (100%), in an unselected group of patients treated in daily routine, suggest high safety and efficacy of FemoSeal vascular closure device in antegrade common femoral artery puncture site hemostasis when using vascular sheaths ranging from 5 to 8 Fr. Therefore, FemoSeal could be considered as a first-line hemostasis strategy in such cases.

scholarly journals A Peculiar Case of a Floating Angio-Seal

2016 ◽  
Vol 10 (1) ◽  
pp. 44-47 ◽  
Author(s):  
R.C. Dettmers ◽  
W.M.P.F. Bosman ◽  
M.A.J. van den Broek ◽  
H.T.C. Veger ◽  
P.Ph.A. Hedeman Joosten ◽  
...  
Keyword(s):  
Lower Limb ◽  
Surgical Intervention ◽  
Vascular Complications ◽  
Limb Ischemia ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Puncture Site ◽  
Lower Limb Ischemia ◽  
Routine Physical Examination ◽  
Peculiar Case

Purpose To show a complication of the use of an Angio-Seal™ closure device. Case We present a patient with a systolic murmur in his femoral artery after PCI. The murmur was caused by a dislocated Angio-Seal™, a vascular closure device. This was diagnosed by Doppler Ultrasound. The device was surgically removed. Conclusion Vascular complications, such as lower limb ischemia, requiring surgical intervention tend to be higher after use of a vascular closure device. We advise routine physical examination of the puncture site after percutaneous closure with a vascular closure device, such as an Angio-Seal™. The removal of the device can be performed via an open or endoscopic approach, based on available experience.

The Use of ExoSeal Vascular Closure Device for Direct Antegrade Superficial Femoral Artery Puncture Site Hemostasis

2014 ◽  
Vol 38 (3) ◽  
pp. 560-564 ◽  
Author(s):  
Uri Rimon ◽  
Boris Khaitovich ◽  
Dmitry Yakubovich ◽  
Paul Bensaid ◽  
Gil Golan ◽  
...  
Keyword(s):  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Closure Device ◽  
Vascular Closure Device ◽  
Puncture Site

Symptomatic vascular complications after vascular closure device use following diagnostic and interventional catheterisation

VASA ◽  
2004 ◽  
Vol 33 (2) ◽  
pp. 78-81 ◽  
Author(s):  
Thalhammer ◽  
Aschwanden ◽  
Jeanneret ◽  
Labs ◽  
Jäger
Keyword(s):  
Current Literature ◽  
Vascular Complications ◽  
University Hospital ◽  
Closure Device ◽  
Ultrasound Guided ◽  
Vascular Closure Device ◽  
Device Use ◽  
Arterial Stenoses ◽  
The University ◽  
Stenotic Lesions

Background: Haemostatic puncture closure devices for rapid and effective hemostasis after arterial catheterisation are a comfortable alternative to manual compression. Implanting a collagen plug against the vessel wall may become responsible for other kind of vascular injuries i.e. thrombotic or stenotic lesions and peripheral embolisation. The aim of this paper is to report our clinically relevant vascular complications after Angio-Seal® and to discuss the results in the light of the current literature. Patients and methods: We report the symptomatic vascular complications in 17 of 7376 patients undergoing diagnostic or therapeutic catheterisation between May 2000 and March 2003 at the University Hospital Basel. Results: Most patients presented with ischaemic symptoms, arterial stenoses or occlusions and thrombotic lesions (n = 14), whereas pseudoaneurysms were extremely rare (n = 3). Most patients with ischaemic lesions underwent vascular surgery and all patients with a pseudoaneurysm were successfully treated by ultrasound-guided compression. Conclusions: Severe vascular complications after Angio-Seal® are rare, consistent with the current literature. There may be a shift from pseudoaneurysms to ischaemic lesions.

Sign in / Sign up

Export Citation Format

Share Document